Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris

Acta Dermato-Venereologica

Volumn 87, Issue 3, 2007, Pages 246-254

  Oprica, Cristina ^a   Emtestam, Lennart ^a   Hagströmer, Lena ^a   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acne; Antibiotics; Oral retinoids; Propionibacterium acnes; Resistance

Indexed keywords

ADAPALENE; ISOTRETINOIN; RETINOL; TETRACYCLINE; ANTIINFECTIVE AGENT; CLINDAMYCIN; DERMATOLOGICAL AGENT; NAPHTHALENE DERIVATIVE;

ABDOMINAL PAIN; ACNE; ACNE VULGARIS; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHEILITIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DRUG WITHDRAWAL; DRY EYE; DRY SKIN; EPISTAXIS; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATORY DISEASE; INTRACRANIAL HYPERTENSION; MALE; MICROBIAL IDENTIFICATION; MICROBIOLOGY; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RANDOMIZED CONTROLLED TRIAL; REMISSION; SAMPLE; SIDE EFFECT; SKIN; SKIN PRURITUS; SKIN REDNESS; XEROSIS; ANTIBIOTIC RESISTANCE; DRUG COMBINATION; ORAL DRUG ADMINISTRATION; QUALITY OF LIFE; SEX DIFFERENCE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DERMATOLOGIC AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOTRETINOIN; MALE; NAPHTHALENES; QUALITY OF LIFE; REMISSION INDUCTION; SEX FACTORS; TETRACYCLINE; TREATMENT OUTCOME;

EID: 34447550856     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0211     Document Type: Article

References (31)

1. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Li Wan Po A, O'Neill C, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364: 2188-2195.
2. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538-544.
3. Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther 2002; 24: 1117-1133.
4. Dreno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004; 14: 391-399.
5. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49: S1-37.
6. Goldsmith LA, Bolognia JL, Callen JP, Chen SC, Feldman SR, Lim HW, et al. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol 2004; 50: 900-906.
7. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
8. Oprica C, Nord CE. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005; 11: 204-213.
9. Oprica C, Emtestam L, Lapins J, Borglund E, Nyberg F, Stenlund K, et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 2004; 10: 155-164.
10. Dreno B. Pathophysiology of acne. Presse Med 2005; 34: 537-539.
11. Katsambas A, Papakonstantinou A. Acne: systemic treatment. Clin Dermatol 2004; 22: 412-418.
12. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003; 20: 405-414.
13. Burke BM, Cunliffe WJ. The assessment of acne vulgaris - the Leeds technique. Br J Dermatol 1984; 111: 83-92.
14. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
15. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology 1998; 196: 140-147.
16. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard - Sixth edition. NCCLS document M11-A6. Wayne, PA: NCCLS, 2004.
17. SAS/STAT Software. Change and enhancements through release 6.12. Cary, NC: SAS Institute Inc., 1997.
18. Chivot M. Acne flare-up and deterioration with oral isotretinoin. Ann Dermatol Venereol 2001; 128: 224-228.
19. Lester RS, Schachter GD, Light MJ. Isotretinoin and tetracycline in the management of severe nodulocystic acne. Int J Dermatol 1985; 24: 252-257.
20. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? implications of resistance for acne patients and prescribers. Am J Clin Dermatol 2003; 4: 813-831.
21. Cove JH, Cunliffe WJ, Holland KT. Acne vulgaris: is the bacterial population size significant? Br J Dermatol 1980; 102: 277-280.
22. Mills O Jr, Thornsberry C, Cardin CW, Smiles KA, Leyden JJ. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol 2002; 82: 260-265.
23. Qureshi A, Ross JI, Snelling AM, Eady EA, Cove JH. Survival of antibiotic-resistant Propionibacterium acnes in the environment. 14th European Congress of Clinical Microbiology and Infectious Diseases 2004, Prague, poster presentation.
24. Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol 2003; 6: 452-456.
25. Morell V. Antibiotic resistance: road of no return. Science 1997; 278: 575-576.
26. Nagaev I, Bjorkman J, Andersson DI, Hughes D. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001; 40: 433-439.
27. Nielsen HU, Hammerum AM, Ekelund K, Bang D, Pallesen LV, Frimodt-Moller N. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist 2004; 10: 231-238.
28. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51-57.
29. Eady EA, Cove JH, Blake J, Holland KT, Cunliffe WJ. Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988; 118: 415-423.
30. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother 1982; 21: 770-772.
31. Layton AM, Dreno B, Gollnick HPM, Zouboullis CC. A review of the European Directive for prescribing systemic isotretinion for acne vulgaris. J Eur Acad Derm Venereol 2006; 20: 773-776.